Clinomics Europe
Medical biotech company specializing in liquid biopsy and NGS technologies for early-stage cancer diagnosis.
Bemutatkozás
Clinomics Europe is a Budapest-based company established in June 2021. The company is committed to helping patients by developing novel precision diagnostic devices and methods. Their core technology is based on early-stage cancer diagnosis through genetic analysis of circulating tumor cells using liquid biopsy and NGS (Next-Generation Sequencing) technologies. The company focuses on research and development of innovative molecular diagnostic methods, including liquid biopsy, next-generation sequencing, and qPCR. Clinomics Europe has a rapidly growing team and is expanding internationally with subsidiaries in the UK and the USA.
Szolgáltatások, tevékenységek
- Liquid biopsy R&D
- Applications
- Clinomics Diagnostics
- Diagnostic packages
- Molecular genetic diagnostics
- Cardiovascular disorders to thrombosis
- Family planning, infertility
- Cancer predisposition
- Nutrigenetics
- Sports genetics
- Genetic counseling
Cím és elérhetőség
Clinomics Europe OfficeIroda
1094 Budapest, Mihálkovics utca 10.
Cégadatok
- Cégnév
- Clinomics Europe
A cégadatok a vállalkozás saját weboldalán közzétett impresszumból származnak.